SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-102822
Filing Date
2023-09-21
Accepted
2023-09-21 16:15:16
Documents
1
Group Members
5AM OPPORTUNITIES II (GP), LLC5AM OPPORTUNITIES II, L.P.5AM VENTURES VII, L.P.ANDREW J. SCHWABKUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2326624d1_sc13g.htm SC 13G 146726
  Complete submission text file 0001104659-23-102822.txt   148523
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90538 | Film No.: 231269267
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Partners VII, LLC (Filed by) CIK: 0001873545 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G